checkAd

     117  0 Kommentare Pressure BioSciences Receives Record Nearly $600,000 Order for 16 PCT Instruments - Seite 3

    Forward Looking Statements

    This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied, or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. In evaluating these statements, you should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause our actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

    For more information about PBIO and this press release, please click on the following website link:
    http://www.pressurebiosciences.com
    Please visit us on Facebook, LinkedIn, and Twitter.

    Press Contacts:

    Richard T. Schumacher, President & CEO
    (508) 230-1828 (T)

    John B. Hollister, Director, Sales and Marketing
    (805) 908-5719 (T)

    Jeffrey N. Peterson, Board Chairman
    (650)703-8557 (T)

    Lesen Sie auch

    SOURCE: Pressure BioSciences Inc.



    View source version on accesswire.com:
    https://www.accesswire.com/737686/Pressure-BioSciences-Receives-Record ...

    Seite 3 von 3




    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    Verfasst von Accesswire
    Pressure BioSciences Receives Record Nearly $600,000 Order for 16 PCT Instruments - Seite 3 Largest Single Order in Company's History was Prepaid as New Chinese Distributor Comes Online;Adds to Revenue Strength Also Building Across PBI's UltraShear Nanoemulsions PlatformSOUTH EASTON, MA / ACCESSWIRE / February 1, 2023 / Pressure …